NCT02544997 2020-07-07A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR PathwaySamsung Medical CenterPhase 2 Completed5 enrolled